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Abstract
Recent studies show that asymmetric sigmoidal response curves are not uncommon
in biomedical studies. For example, the 5-parameter logistic (5PL) model is
frequently used to model and analyze responses from bioassays and immunoassays
which can be skewed. Various types of optimal experimental designs for 2, 3 and
4-parameter logistic models have been reported but not for the more complicated
5-parameter logistic (5PL) model. Designs currently used for the 5PL model seem
ad-hoc with no formal quantitative assessment of their efficiencies. We construct
different types of optimal designs for studying various features of the 5PL model
and use them to evaluate efficiencies of commonly used designs in bioassays and
immunoassays. We also create a user-friendly software package to search for optimal
designs tailor-made to user-specified problems for the 5PL model and evaluate
robustness properties of the design under a variation of criteria, model forms
and mis-specification in the nominal values of the model parameters. Our design
strategies can also account for several objectives with varying degrees of importance.
As an application, we generate optimal designs for the 5PL model for real studies
in immunoassays and bioassays, and show currently used designs are generally
inefficient for statistical inference.
Keywords
Approximate Design, Asymmetric Calibration Curves, D-optimal design, Robust
Optimal Design, Toxicology
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1 Introduction
In toxicology assays, it is often assumed that the response has a symmetric
sigmoidal relationship with dose (concentration) and the logistic regression
models such as the 3-parameter parameter (3PL) and the 4-parameter logistic
(4PL) model are widely used to capture the symmetrical relationship. Recent
studies show that asymmetrical response curves are often observed in various
bioassays and immunoassays1–4. For such asymmetrical sigmoidal response
curves, the 3PL and 4PL models are inappropriate. Gottschalk and Dunn5
showed that the 5-parameter logistic (5PL) model is able to capture the
asymmetric relationships adequately and produce dramatically more accurate
inference for the assays compared to results using the 3PL or 4PL models.
Statistical inference for bioassays and immunoassays based on the 5PL model
is not new. For example, Findlay and Dillard6 applied the 5PL model to fit the
data for ligand binding assays and Feng et al.7 presented a Bayesian approach
to fit the 5PL model using data from an enzyme-linked immunosorbent assay
(ELISA). Dawn et al.8,9 used a modified 5PL model (5PL-1P) to capture the
asymmetry in mixture toxicity assessment. Cumberland10 discussed the choice
between the 4PL and 5PL models for estimation purposes; see also model
fitting issues using biological data for these models in Davis et al.11. Another
application of the 5PL model is Gottschalk and Dunn12, who applied the model
for measuring parallelism and relative potency in biological applications.
The design of a scientific study plays a crucial role in the accuracy of the
inference that follows. Many of the above studies for the 5PL model used
between 5 and 10 evenly spaced design points on the log scale with equal
replications. This seems to be the current practice even though there is very
little research in the literature to support such design choices. The only design
work we were able to find is that from Manukyan and Rosenberger13, who found
locally D-optimal designs for the 5PL model when the response is binary.
The 3, 4 and 5PL models are frequently used to describe sigmoidal response
curves and use of a wrong model can produce highly inaccurate or wrong
inference. For example, optimal designs for the 3PL model cannot estimate
all parameters in the 5PL model and an optimal design for the 5PL model can
perform poorly when the 3PL or 4PL model holds. The implemented design
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should therefore be robust to mis-specifications of the nominal values, model
assumptions and under a variation of criteria.
In practice, there are several objectives in the study and some are more
important than others. This calls for a multiple-objective optimal design that
can deliver user-specified efficiencies commensurate with the importance of
each of the objectives. Such an optimal design is also appropriate when some
parameters in the model are more interpretable than others. For instance
in the widely used two-parameter Michaelis-Menten model in the biological
sciences, the Michaelis-Menten parameter is more interesting than the saturation
parameter because it governs how fast the enzyme-substract kinetics reaction
velocity is. It follows that the user should devote more resources to estimating
the more interesting parameter or parameters so that they are more accurately
estimated. Research to date shows a multiple-objective optimal design generally
has overall higher efficiencies across all objectives than any of the single objective
optimal designs can provide, see for example14,15. The former proposed a
graphical approach to find dual-objective optimal designs using efficiency plots
and, Hyun and Wong15 gave a step-by-step approach to find 3-objective optimal
designs for a nonlinear model. Of course, if the efficiencies sought under all the
objectives are too high, a multiple-objective optimal design may not exist.
This paper has two aims. The first is to find various types of optimal designs
for the 5PL model and incorporate model uncertainty at the design stage at the
same time. Specific designs that seem helpful for bioassays and immunoassays
using the 5PL model are optimal designs to accurately estimate (1) the model
parameters in the model or (2) a target dose such as the EC50(ED50) that
results in having one half of test subject having the maximal expected response.
Since model uncertainty is always an issue, we also develop optimal designs for
discriminating among the 3PL, 4PL and the 5PL models. Additionally, we find
multiple-objective optimal designs for the 5PL model and construct a robust
D-optimal design that performs well for estimating the model parameters in the
3PL, 4PL or 5PL models regardless which one of them holds.
Our second aim is to facilitate practitioners implement various optimal designs
for the 5PL model. To this end, we provide an R package that generate optimal
designs discussed in this paper and compare robustness properties of the designs
to various departures from the model assumptions. Because the 5PL model is an
extension of the 3PL and 4PL models, our functions can also readily find various
optimal designs for the 3PL and 4PL models. As an application, we construct
an optimal design that performs well for various objectives and model forms
in a real immunoassays and bioassays study and report benefits of using our
recommended design versus commonly recommended designs for such studies.
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Section 2 describes the response curve, interprets the meaning of each
parameter in the 5PL model and the Fisher information matrix. Section 3
presents locally optimal designs for studying 3 interesting features under the
5PL model and the robust D-optimal design that performs well for the 3PL,
4PL, and 5PL models for estimating model parameters. In Section 4, we propose
an algorithm with R functions to search for all the optimal designs in this paper.
In Section 5, we study sensitivities of the locally D-optimal design for the 5PL
model to various mis-specifications in the model assumptions. In Section 6,
we recommend an optimal design for use in immunoassays and bioassays, and
shows it outperforms currently used designs by practitioners. Section 7 contains
a conclusion with a summary of our work and future directions.
2 Background
Let X be the user-selected compact design space from which the design points
are selected to observe the observations. Let Yij be the continuous response
from the jth replicate at xi ∈ X, j = 1, . . . , ni, i = 1, . . . ,K. Assume that we
have resources to take a predetermined number of observations N so that
n1 + . . .+ nK = N . Given a design criterion, the design questions are the
optimal number (K) of design points to use, the optimal number of replicates
(ni) and the location of each design point xi, i = 1 . . . , xK .
Our statistical models have the form
Yij = f(xi,Θ) + ǫij , j = 1, 2, . . . , ni, i = 1, 2, . . . ,K, n1 + · · ·+ nK = N, (1)
where f(xi,Θ) is the mean response at xi. The errors ǫijs are independent and
normally distributed with means 0 and unknown variance σ2.
We focus on approximate designs or large sample designs where we
approximate each ni/N by its proportion. We denote such a design by ξ =
{(xi, wi)}
K
1 where each xi ∈ X , wi ∈ (0, 1) and w1 + . . .+ wK = 1. In dose-
response experiments, optimal design issues concern the total number of
concentrations to be used (K), where these K concentration levels or design
points xi xi, i = 1, 2, . . . ,K are, and the proportions wi, i = 1, . . . ,K of subjects
to be allocated to each of these concentrations. Approximate designs can be
studied under a unified framework and there are algorithms for finding many
types of optimal designs. Formulae for such designs are available for many
models and they facilitate studying properties of the optimal approximate
designs. In addition, there are theoretical tools for verifying if an approximate
design is optimal among all designs and the optimal approximate designs do not
depend on the value of N by definition.
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We measure the worth of a design by its Fisher information matrix. For the
approximate design ξ, the normalized Fisher information matrix is
I(ξ; Θ) =
1
σ2
K∑
i=1
wig(xi)
⊤g(xi), (2)
where g(x) =
(
∂f(x,Θ)
∂θ1
, ∂f(x,Θ)∂θ2 , . . . ,
∂f(x,Θ)
∂θv
)
and v is the number of
model parameters. Since a ’large’ information matrix is desirable for statistical
inference, many optimality design criteria seek a design that makes this matrix
as large as possible in different ways.
For the 5-parameter logistic(5PL) model, the mean response f(x,Θ) is
f(x,Θ) =
θ1 − θ4[
1 + ( θ3x )
θ2
]θ5 + θ4, (3)
where θ1 and θ4 are the maximum and the minimum expected responses
respectively, θ2 controls the stiffness of the response curve, θ3 is the position
of the transition region in concentration, and θ5 is the asymmetric factor and
positive. the parameters θ2 and θ5 jointly control the slope of the response curve.
Clearly, the 5PL model becomes the 4-parameter logistic(4PL) model when θ5
takes the value of 1, and it becomes the 3-parameter logistic(3PL) model when
θ4 and θ5 take the values of 0 and 1 respectively.
For the 5PL model, the vector g(x) has components given by
∂f(x,Θ)
∂θ1
= (1 +D)−θ5 ;
∂f(x,Θ)
∂θ2
= −
(θ1 − θ4)θ5
θ2
D(1 +D)−1−θ5 log(D);
∂f(x,Θ)
∂θ3
= −
(θ1 − θ4)θ2θ5
θ3
D(1 +D)−1−θ5 ;
∂f(x,Θ)
∂θ4
= 1− (1 +D)−θ5 ;
∂f(x,Θ)
∂θ5
= −(θ1 − θ4)(1 +D)
−θ5 log(1 +D),
Prepared using sagej.cls
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where D =
(
θ3
x
)θ2
. A direct calculation shows the normalized Fisher
information matrix (2) is I(ξ; Θ) = AM(ξ; Θ)A⊤, where
A =

1 0 0 0 0
0 −(θ1−θ4)θ5θ2 0 0 0
0 0 −(θ1−θ4)θ2θ5θ3 0 0
−1 0 0 1 0
0 0 0 0 −θ1 + θ4
 ,
M(ξ; Θ) =
1
σ2
K∑
i=1
wig
∗(Di)
⊤g∗(Di), ϕ(Di) = (1 +Di)
−θ5
and g∗(Di) = ϕ(Di)
(
1, Dilog(Di)1+Di ,
Di
1+Di
, ϕ(Di)
−1, log(1 +Di)
)
. The
matrix A does not contain any concentration level or weight and this implies
that maximizing some function of M(ξ; Θ) is equivalent to maximizing the same
function in I(ξ; Θ). We observe that M(ξ; Θ) contains only the 3 parameters θ2,
θ3, and θ5, and so any classical optimal design such as D-, A-, c-, or Ds-optimal
design for model (3) does not depend on the parameters θ1 and θ4.
3 Optimal designs
In practice, the choice of an optimal design depends on the objective or
objectives of the study. They can vary from estimating all or some model
parameters to predicting mean response at a location in the design space
or minimizing the sum of elements in the covariance matrix. Frequently, the
criterion is formulated as a convex function of the information matrix so that
we can use an equivalence theorem to check if the design is optimal among
all designs. The equivalence theorem is derived from the directional derivative
consideration and is unique for each convex functional. However they all have
a general form in terms of an inequality with 0 on the right hand side of the
inequality. The function on the left hand side of the inequality is called the
sensitivity function of the design in the literature; see design monographs such
as Fedorov16.
The information matrix for a nonlinear model depends on the model
parameters and so our optimal design depends on the unknown parameters. Such
designs are termed locally optimal17. These optimal designs can be sensitive to
the nominal values and so they must be selected carefully. However, they are
the easiest to find and are important because they typically represent a first
step to finding more complex designs18. Two approaches that do not require
a set of single best guesses for the values of the parameters to find optimal
Prepared using sagej.cls
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designs are the Bayesian and minimax or maxmin approaches. The former
requires a prior distribution for the parameters and the latter requires the user to
specify a plausible region of possible values for all the parameters. Both methods
generalize the concept of locally optimal designs and both Bayesian and minimax
type of optimal designs are clearly much more difficult to find, theoretically or
computationally, than locally optimal designs. For example, minimax optimal
designs are found under a non-differentiable criterion and there are no effective
algorithms for finding them for a general regression model. Chen19 provides
examples of minimax and standardized minimax optimal designs, including
showing how locally optimal designs are first determined before a standardized
minimax optimal design is found. Recent work on maximin optimal designs,
which are equivalent to minimax optimal designs, and Bayesian optimal designs
are Coffey20 and McCallum and Bornkamp21, respectively, among others. For
space consideration, these two approaches will not be further discussed here.
We now review several types of locally optimal designs commonly used in
practice. In what is to follow we use the terms locally optimal designs and
optimal designs interchangeably when there is no room for confusion.
3.1 D-optimal designs for estimating Θ
D-optimal designs are the most appropriate when the interest in the study is
to estimate the vector of model parameters Θ as accurately as possible. The D-
optimal design ξD maximizes the determinant of the Fisher information matrix
I(ξ;Θ): Ψ = |I(ξ;Θ)|. Equivalently, for fixed Θ, we want a design that minimizes
the convex function −log |I(ξ;Θ)|. The directional derivative of the D-optimality
criterion leads to the sensitivity function: dD(x, ξ) = g(x)I
−1(ξ; Θ)g(x)⊤ − 5.
Under the 5PL model, the Equivalence Theorem for D-optimality is that the
design ξD is the D-optimal design if and only if for all x in X
dD(x, ξD) ≤ 0,
with equality at the design points of the design ξD.
3.2 c-optimal designs for estimating the EC50
c-optimal design is used when the goal is to estimate a function of model
parameters. The EC50 is the concentration producing a response that is half way
between the expected maximum and minimum responses of the curve. Under
the 5PL, the EC50 is expressed as a function of Θ and is given by
EC50 = arg
x
{f(x,Θ) =
1
2
(θ1 + θ4)} = θ3(2
θ−1
5 − 1)−1/θ2 .
Prepared using sagej.cls
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Let ÊC50 be the maximum likelihood estimate of EC50. The c-optimal design
for estimating the EC50, ξc minimizes the asymptotic variance of estimating the
EC50: Ψ = V ar(ÊC50) = EC
′
50I
−1(ξ; Θ)[EC′50]
⊤, where EC′50 is the derivative
of the EC50 with respect to Θ:
EC′50 =
(
0, 1
θ2
2
EC50log(2
θ−1
5 − 1), 1θ3EC50, 0,
1
θ2θ
θ2
3
θ2
5
2θ
−1
5 ECθ2+150 log(2)
)
.
Consideration of the directional derivative of the c-optimality criterion leads to
the sensitivity function:
dc(x, ξ) =
(g(x)I−1(ξ; Θ)[EC′50]
⊤)2
EC′50I
−1(ξ; Θ)[EC′50]
⊤
− 1,
and the Equivalence Theorem states that the design ξc is the c-optimal design
if and only if for all x in X
dc(x, ξc) ≤ 0,
with equality at the design points of the design ξc.
3.3 D
s
-optimal designs for estimating the θ5
Ds-optimal design is used when the goal is to estimate a subset of the model
parameters. Due to this characteristic, it is often used for testing nested models.
When the 5PL model is used, one interesting question is discriminating between
the 4PL and 5PL models (i.e, testing the significance of θ5 = 1 since the 5PL
model becomes the 4PL model when θ5 = 1). To discriminate between the
4PL and the 5PL model effectively, we need to find a design that minimizes
the asymptotic variance of the estimated θ5 or find the Ds-optimal design for
estimating it with minimum variance.
The Fisher information matrix (2) can be partitioned as
I(ξ; Θ) =
1
σ2
(
I11(ξ; Θ) I12(ξ; Θ)
I21(ξ; Θ) I22(ξ; Θ)
)
, (4)
where Iuv(ξ; Θ) =
∑K
i=1 wigu(xi)
⊤gv(xi), u, v = 1, 2. Here
g1(x) =
(
∂f(x,Θ)
∂θ1
, ∂f(x,Θ)∂θ2 ,
∂f(x,Θ)
∂θ3
, ∂f(x,Θ)∂θ4
)
and
g2(x) =
(
∂f(x,Θ)
∂θ5
)
.
The variance of the estimated θ5 is equal to
I22(ξ; Θ) = {I22(ξ; Θ)− I21(ξ; Θ)I
−1
11 (ξ; Θ)I12(ξ; Θ)}
−1.
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The Ds-optimal design ξDs for estimating θ5 is the one that minimizes this
variance and equivalently the one that maximizes the determinant
Ψ = |I22(ξ; Θ)− I21(ξ; Θ)I
−1
11 (ξ; Θ)I12(ξ; Θ)| =
|I(ξ; Θ)|
|I11(ξ; Θ)|
.
The directional derivative of the Ds-optimality criterion for estimating a subset
of s of the parameters leads to the sensitivity function:
dDs(x, ξ) =
{
g(x)I−1(ξ; Θ)g(x)⊤ − g1(x)I
−1
11 (ξ; Θ)g1(x)
⊤
}
− s.
In our case, since we have only one parameter of interest, we set s = 1. The
Equivalence Theorem states that the design ξDs is the Ds-optimal design if and
only if for all x in X
dDs(x, ξDs ) ≤ 0,
with equality at the design points of the design ξDs . In this case, Ds-optimal
design for estimating θ5 is equivalent to c-optimal design for estimating θ5 since
the c-optimal design minimizes the asymptotic variance of the estimated θ5.
3.4 Design efficiency
We use design efficiency to compare the worth of a design relative to the
optimum. This is a value between 0 and 1 and frequently it is simply the ratio
of the optimal values of the criterion evaluated for the two designs or some
simple function thereof. The interpretation of the efficiency of a design is that
if its value is r, this design requires 100(1/r− 1)% more observations to do as
well as the optimal design. For example, when eD(ξ) = 0.5 for a given design ξ,
this design requires 200% more observations to provide the same D-optimality
criterion value as the D-optimal design does and this tells that twice as many
observations are required for the design to be as efficient as the D-optimal design.
The performance of a design ξ for estimating Θ is given by its D-efficiency:
eD(ξ) =
(
|I(ξ; Θ)|
|I(ξD; Θ)|
) 1
5
.
For estimating a given function of the model parameters, its c-efficiency for
estimating EC50 is
ec(ξ) =
EC′50I
−1(ξc; Θ)[EC
′
50]
⊤
EC′50I
−1(ξ; Θ)[EC′50]
⊤
,
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ξc is a EC50-optimal design. In particular, its efficiency for estimating the single
parameter θ5, is
eDs(ξ) =
|I(ξ; Θ)|/|I11(ξ; Θ)|
|I(ξDs ; Θ)|/|I11(ξDs ; Θ)|
.
In practice, we want the implemented design to have high efficiency under
the user-specified criterion and preferably a design with high efficiencies under
a variation of criteria and a broad class of models.
3.5 A Robust D-optimal design to model mis-specification
Locally optimal designs for nonlinear models can be sensitive to mis-specification
in the regression model and the nominal values for the model parameters. The
5PL model becomes the 3PL or 4PL model when some of its model parameters
take on specific values. Here we propose a robust D-optimal design that works
well for estimating the model parameters for the 3PL, 4PL, and 5PL models.
Let Θ1, Θ2, Θ3 be the vectors of model parameters for the 3PL, 4PL, 5PL
models respectively and let g1(x), g2(x), g3(x) be the gradients of the mean
functions under the 3 models respectively. The normalized Fisher information
matrices for the 3 models are
It(ξ; Θt) =
1
σ2
K∑
i=1
wig
t(xi)
⊤gt(xi), t = 1, 2, 3.
Following Cook and Wong14 and Atkinson22, we use a compound design
criterion to construct an efficient design to estimate the model parameters
accurately regardless which one of the 3 models holds. The sought design is the
one maximizes a user-selected weighted average of the 3 D-optimality criteria
for the 3 models:
Ψ =
3∑
t=1
λi
pt
log(|It(ξ; Θt)|), (5)
where for simplicity, we suppress dependence of the criterion on the design,
weights and the model parameters. Here, pt is the number of model parameters
for each model, each λi is non-negative and
∑3
t=1 λt = 1. λi may be viewed as
the prior probability that the ith model holds. By taking directional derivative
of the compound criterion, one can show the sensitivity function of the criterion
is
dRoD(x, ξ) =
{
3∑
t=1
λt
pt
dt(x, ξ)
}
− 1. (6)
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Here dt(x, ξ) = g
t(x)I−1t (ξ; Θt)g
t(x)⊤ and by the Equivalence Theorem, the
design ξRoD is the robust D-optimal design if and only if for all x in X
dRoD(x, ξRoD) ≤ 0,
with equality at the design points of the design ξRoD.
4 An algorithm and R-package
Yang23 introduced an efficient algorithm to search several types of optimal
designs for nonlinear models and showed that it outperforms other well known
standard design algorithms. Hyun, Wong and Yang24 modified their algorithm
to search the optimal designs more efficiently and this modified algorithm is used
to search all the optimal designs in this paper. The modified algorithm runs
based on the sensitivity function d(x, ξ) (i.e, the directional derivative of the
optimality criterion) and the first and the second derivatives of the optimality
criterion with respect to the weights, ∂Ψ∂wi and
∂2Ψ
∂wiwj
. The algorithm selects good
initial design points via the Fedorov’s algorithm16 and at each iteration, it selects
a design point that maximizes d(x, ξ) and adds to the previously selected design
points. Then the optimal weights for the selected design points are obtained
by the Newton Raphson’s method using ∂Ψ∂wi and
∂2Ψ
∂wiwj
. Lastly the obtained
optimal design is verified by the General Equivalence Theorem25. Base on the
algorithm, we developed an R packageOpt5PL to search all the optimal designs
in this paper and the package is available in the Comprehensive R Archive
Network (https://CRAN.R-project.org/package=Opt5PL). The description
showing examples of searching optimal designs using the package is given in
the supporting web materials of this paper. This R package contains several
functions (ROPT, EDpOPT, DsOPT, Deff, EDpeff, Dseff) useful for obtaining and
evaluating optimal designs under the 5PL models. Some functions also can be
used to study optimal designs for the 3PL or 4PL models.
The ROPT function obtains the robust D-optimal design for the model
uncertainty between the 3PL, 4PL, and 5PL models. In addition, the function
can be used to obtain D-optimal design for each of the 3 models. The ROPT
function maximizes the compound optimality criterion (5) in this paper and
verifies the optimality of the generated design using the General Equivalence
Theorem by producing a graphical plot of the sensitivity function (6).
The EDpOPT and DsOPT functions obtain c-optimal design for estimating the
ECp and Ds-optimal design design for estimating θ5 under the 5PL model
respectively, and they also verify the obtained optimal designs using the the
General Equivalence Theorem. Here the ECp is the concentration level that
Prepared using sagej.cls
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achieves the 100p% of the difference between the maximum and the minimum
responses. By setting p = 0.5, the EDpOPT function can find the c-optimal design
for estimating the EC50 under the 5PL model.
The Deff, EDpeff, Dseff functions obtain D-efficiency for estimating Θ, c-
efficiency for estimating the ECp, and Ds-efficiency for estimating θ5 under
the 5PL model respectively. These functions obtain the efficiencies of any given
design ξ. The function Deff also can be used to compute the D-efficiencies under
the 3PL and 4PL models. In the following applications, all the optimal designs
for the 5PL model and their performances are obtained using this R functions.
5 Robustness of D-optimal design for the 5PL model
5.1 Robustness to the model parameter values and to the 4PL model
The 5PL model can capture more various dose-response relationships compared
to the 4PL model since it can control an asymmetric levels of the response curve.
We believe there must be some advantages of using the optimal designs for the
5PL model over the optimal designs for the 4PL model. Here we compare the
D-optimal design for the 5PL model to practically efficient optimal designs for
the 4PL model and check the robustness of the D-optimal design to various
model parameter values and to the different model, the 4PL model.
Holland26 presents practically useful cD-optimal designs for estimating the
model parameters and the EC50 simultaneously under the 4PL model. The cD-
optimal design combines the requirements for the c- and D-optimal designs in
some ways, so that the obtained design provides a user-specified efficiency for
estimation of both the model parameters and the EC50. These optimal designs
work well for the 4PL model that describes symmetrical sigmoidal response
curves. However, there is a doubt if the optimal designs under the 4PLmodel still
work well for the 5PL model which can account for asymmetrical relationships.
Here we consider their 3 cD-optimal designs that provide competitive
efficiencies for the two objectives under the 4PL model and ascertain whether
they still perform well for the same objectives under the 5PL model. The 3
optimal designs ξ4PLi , i = 1, 2, 3 were obtained using 3 approaches: i) maximizing
a weighted geometric average of c- and D- criteria; ii) two stage procedure using
the idea of design augmentation in Padmanabhan27; iii) maximizing a weighted
geometric average of c- and D- criteria under some constraint. So the 3 designs
correspond to the designs 2,3b, and 4b in Table 1 of Holand-Latz’s paper26. We
compare them with the D-optimal design for the 5PL model ξ5PLD and evaluate
the robustness of the 4 designs to mis-specified parameter values.
The same setup in Holland26 is used: a true value of Θ2 = (1, 1, 1, 0) for the
4PL model and set θ5 = 1 for the 5PL model, so Θ3 = (1, 1, 1, 0, 1); and the log
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concentration range is between -5 and 5. Table 1 shows the performances of
the 4 designs ξ4PL1 , ξ
4PL
2 , ξ
4PL
3 , and ξ
5PL
D for estimating the model parameters
and the EC50 under the 5PL model using D- and c-efficiency, e
5PL
D and e
5PL
c .
To ascertain whether the optimal designs are robust to nominal values of the
model parameter, we fix the true value of θ5 = 1 and compute optimal designs
with values of θ5 different from unity and compare changes in their efficiencies
when we make various assumptions on the asymmetrical aspects of the response
curves. Table 1 shows these efficiencies when nominal values for θ2 and θ3 are
fixed. Table A1 and A2 in Web Appendix A show corresponding results for
different values of θ2 and θ3.
Table 1 about here
The cD-optimal designs for the 4PL model perform poorly overall for the 5PL
models with various asymmetric factor levels. The design ξ4PL2 performs better
than the other two cD-optimal designs but their efficiencies are unsatisfactory
and they change dramatically in the c-efficiency for different values of θ5. Similar
results are observed for the cD-optimal designs for different values of θ2 and
θ3 under the 5PL model. This is an expected result because the cD-optimal
designs are obtained under the 4PL model and optimal designs for nonlinear
models usually become inefficient when they are used for a different model.
One interesting finding is the cD-optimal designs don’t perform well even when
θ5 = 1 for the 5PL model. The 5PL model becomes identical to the 4PL model
when θ5 = 1 but their Fisher information matrices are still different, so the
optimal designs for the 4PL model becomes inefficient when they are used for
the 5PL model. This reinforces the importance of considering the 5PL model
to construct the optimal designs and shows how the designs obtained from the
4PL model perform inefficiently when they are used for the 5PL model which
can account for the asymmetrical relationship.
In contrast, the D-optimal design ξ5PLD works well for estimating the model
parameters for the different values of θ2, θ3, and θ5. The c-efficiencies of ξ
5PL
D
are lower than its D-efficiencies but mostly they are higher than ones for the
cD-optimal designs, and they don’t show any dramatic changes except the cases
when the values of θ2 and θ5 are far from the true value such as θ2, θ5 = 0.5 or
2.0. It seems the D-optimal design for the 5PL model is more resistant to the
changes in the values of θ3 than the changes in θ2 and θ5. In a similar way, we
also check the robustness of ξ5PLD to the 4PL model. Under the 4PL model, θ3
represents the EC50 and θ2 represents the slope at the EC50. Table 2 assumes
the 4PL model and compares the D-efficiencies, e4PLD , and the c-efficiencies,
e4PLc of the 4 designs for different values of θ3. Table A3 in Web Appendix A in
the supporting web materials displays results for different values of θ2.
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Table 2 about here
The D-optimal design for the 5PL model ξ5PLD performs well for both
objectives under the 4PL model for the various values of θ3. For different values
of θ2, ξ
5PL
D still provides competitive D- and c-efficiencies compared to the
cD-optimal designs but the efficiencies becomes lower when the slope becomes
higher(θ2 > 1.8). Since ξ
5PL
D does not take into account c-optimality criterion for
estimating the EC50, it provides relatively lower c-efficiencies than D-efficiencies
for both the 4PL and the 5PL model but the c-efficiencies can be improved by
applying the same approaches to combine c- and D-optimality criteria using the
5PL model.
5.2 Robustness to the 5PL model for binary response data
In this paper, the 5PL model is used to define the mean of a continuous response.
Sometimes the 5PL model is used to define the probability of observing an
interesting event(i.e., P(Y=1)) for a binary response. When the 5PL model
is used for a binary response, the Fisher information matrix is written as
IB(ξ; Θ) =
1
P (1−P )
∑K
i=1 wig(xi)
⊤g(xi), where P = f(x,Θ) and g(x) is still the
gradient of the 5PL model. For a binary response, the information matrix is
different from one for a continuous response I(ξ; Θ) in (2), so the optimal designs
under the 5PL model for a binary response become different from ones for
a continuous response. For simplification, from now on, the 5PL model for a
continuous response and the 5PL model for a binary response are denoted by
5PLC and 5PLB respectively. In this section, we want to see how the optimal
designs for 5PLC work under 5PLB.
Here the same log concentration range [−5, 5] and the same standard
parameterization for Θ3 are used to obtain the optimal designs. In order to
check the robustness of the optimal designs for 5PLC to 5PLB, D-, c- and
Ds-efficiencies based on IB(ξ; Θ), e
5PLB
D ,e
5PLB
c , and e
5PLB
Ds
are computed, and
we see how the D-, c- and Ds-optimal designs for 5PL
C works compared to
the corresponding optimal designs for 5PLB under various parameter values
of θ2, θ3, and θ5. Let ξ
∗
D denote the D-optimal design for 5PL
C with Θ3 =
(1, 1, 1, 0, 1). We also check how the D-optimal design for 5PLC with the
standard parameterization works robustly to different objectives and different
parameter values under 5PLB. Table 3 shows the efficiencies of optimal designs
for 5PLC when they are used for 5PLB with various θ5 values. The same tables
for different values of θ2 and θ3 are given in the supporting web materials (Tables
A4 and A5 in Web Appendix A). It seems the D-optimal design for 5PLC
performs good when it is used for D-optimality under 5PLB and also it works
robustly to different parameter values. In contrast, for c- and Ds- optimality
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cases, the optimal designs for 5PLC doesn’t work effectively when they are
used for 5PLB.
Table 3 about here
6 Applications
In this section, two real studies are considered to implement the proposed
optimal designs and compare with currently used designs by practitioners.
Study 1: Bio-Plex cytokine assays are described extensively in www.bio-rad.
com, www.biocompare.com, among other web sites. We used the setup described
in the technical report11 and considered Bio-Plex cytokine assays that are bead-
based multiplex sandwich immunoassays. The models of interest are the 4PL
and the 5PL models, which have been shown to be appropriate for fitting data
from such assays. There are two recommended setups for the assays in order
to achieve efficient performance. One is a high-sensitivity range standards (0.2-
3,200 pg/ml) and the other one is a broad range standards (1.95-32,000 pg/ml).
The broad range standards is considered to study optimal designs. When the
logistic model is considered, at least 5 standards(concentrations) for the 4PL
model and 6 standards for the 5 PL model are required but a total of 8 evenly
distributed standards in the range are recommended for an accurate fit. Based
on a 4 fold dilution series, the broad range standard has 8 design points (1.95,
7.8, 31.25, 125, 500, 2,000, 8,000, 32,000).
Study 2: Dawn et al8 assessed toxicity of four chemical agents alone and in
mixture using the 5PL-1Pmodel. The 5PL-1Pmodel is a modified 5PL model by
removing the minimum response parameter. For concentration-response curves,
they fitted the model to each single chemical or their mixture at three different
exposure durations: 15, 30 and 45 min. The experimental design in the study
prepared test concentrations by serial dilution using 1.867 as the dilution
factor. Among the four agents, two agents that has the same concentration
range(7-300 mg/L) are considered to study optimal designs. One is ethyl
chloroacetate(ECAC) and the other one is 3-methyl-2-butanone(3M2B). Based
on the dilution factor, the design has 7 design points (7.09, 13.24, 24.71, 46.12,
86.10, 160.70, 300.00) and two replications at each design point.
In what is to follow, we obtain various optimal designs for the 5PL model
and evaluate how well the above recommended designs are relative to the
optimal designs. The optimal designs are locally optimal in that they depend
on the nominal set of values for the model parameters. Specifically, we compare
performances of the original designs used in the actual studies to the optimal
designs for the 3 criteria discussed earlier. For each study, the original design
has equal weights for the given design points.
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6.1 Optimal designs for fitting the 5PL model
In Study 1, the investigators used the 5PL model to study cytokine assays
over a pre-specified range of concentrations between 1.95 and 32,000. The set
of nominal values for the model parameters is Θ3 = (30, 000, 1, 800, 0.5, 1). To
simulate various response curves over the same range, we created 6 different sets
of possible values of (θ2, θ5) commensurate with values of θ1, θ3, and θ4 in their
work. Results from previous section suggest that the locally D-optimal design
for the 5PL model is more sensitive to this two parameters θ2 and θ5, and we
wish to assess how other designs perform for estimating different aspects of the
curve. Figure 1 shows these 6 response curves from the broad range design ξS1.
Each single chemical in Study 2 has three different response curves based
on the three different exposure times. In Dawn’s paper8, they provided the
estimated parameter values of the EC50, the slope, and the asymmetric factor
when the 5PL-1P model was fitted to each of the agents. So, the 6 different
sets of parameter values for the two agents ECAC and 3M2B are adopted to
create 6 additional response curves of the 5PL model. The paper didn’t provide
the parameter estimates for the maximum and the minimum responses. The
optimal designs for the 5PL model do not depend on these two parameter values
as mentioned earlier. For illustration purpose, we assume their values are 100
and 0 respectively since the response is a toxicity effect(0-100%) in the study.
Figure 2 shows these 6 additional response curves from the design in Study 2
ξS2.
Figure 1 about here
Figure 2 about here
Table 4 shows all the parameter values of the 5PL model for Study 1 and
2. Table A6 and A7 in Web Appendix A in the supporting web material lists
the locally D-optimal designs ξD, locally c-optimal designs ξc, and locally Ds-
optimal designs ξDs for the 5PL models. The suggested guideline for fitting the
5PL model requires at least 6 design points, and so one may add two evenly
spaced design points between the second and the fourth design points of ξD on
the log scale, and call this an extended D-optimal design ξExD. The extended
D-optimal design has equal weight across the seven design points. The two
additional design points of ξExD are also given in the tables along with other
optimal designs.
Table 4 about here
Table 5 shows how the 3 designs, ξD, ξExD, and the original design ξS1 or
ξS2 perform under the 3 objectives. For both studies, it seems that the locally
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D-optimal design still has high efficiencies for the other two objectives. For
estimating the EC50 in Study 1, it provides various efficiencies between 0.55 and
0.90. It seems the efficiency becomes lower when the slope of the response curve
is stiff but the D-optimal design provides satisfactory efficiency for estimating
the EC50 when the response is gradually increased. The extended D-optimal
design cannot perform well as the D-optimal design does but it still provides
efficiencies of between 0.60 and 0.70 regardless of the different parameter values.
The actual design ξS1 in Study 1 works poorly for estimating the EC50 and
the model discrimination and it provides nearly 0 efficiencies when the slope
is steep. The actual design ξS2 in Study 2 performs close to the extended D-
optimal design for all three objectives. If researchers want to find optimal designs
that provide more balanced efficiencies or user-specified efficiencies for the 3
objectives, the multiple-objective optimal design approach in Hyun, Wong and
Yang24 can be applied. The overall message from the table is that the extended
D-optimal design will be practically useful since it provides constant efficiencies
disregarding the changes in the parameter values, and it performs much better
than the actual design when the response curve has a stiff slope. In addition,
it works as well as the D-optimal design when the goal is for estimating the
model parameters and the efficiencies for the other objectives can be increased
by adopting the multiple-objective optimal design approach.
Table 5 about here
6.2 Robustness of the optimal designs to different models
Most commonly used models in immunoassays and bioassays are the 4PL and
the 5PL models and sometimes the 3PL model. All these 3 models are used to
describe a sigmoidal curve for the mean response. Now we want to find a design
that works well for the 3 models. The robust D-optimal design introduced in
this paper can provide well balanced efficiencies for estimating model parameters
under the 3 models.
The model parameter values for the 3 models need to be specified in order
to find the robust D-optimal design. For illustration, we assume that the 6
sets of parameter values for each of Study 1 and 2 are true for the 5PL model
and the mean responses of the 5PL model at the design points of the actual
design are used to estimate the model parameters, Θˆ1 and Θˆ2 for the 3PL and
the 4PL models respectively. For Study 1, eight mean responses corresponding
to the eight design points of ξS1 are generated from the 5PL model with the
given parameter values and use them to obtain the least square estimates of the
parameters for the 3PL and the 4PL models, and the parameter estimates for
the 3PL and the 4PL models for Study 2 are obtained in the same way using ξS2.
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Their estimates are obtained using nlm in R program. Based on the criterion
(5) and assuming the 3 models are equally plausible (i.e., λ1 = λ2 = λ3 = 1/3),
the robust D-optimal designs ξRoD are obtained for both studies (see Table A8
and A9 in the Web Appendix A). The table shows that the robust D-optimal
design always includes the 2 endpoints, and the middle points and their weights
are changed variously.
Table 6 shows the D-efficiencies of the designs ξS1, ξS2, ξExD, ξD, ξRoD across
the different models (3PL,4PL,5PL) under the 6 different sets of parameter
values for Study 1 and 2. The D-efficiencies under the 3PL and 4PL models
are calculated using the definition in Section 3.4 assuming one of the 3 models
is the true model and the parameters are correctly specified. For Study 1, the
actual design has reasonable efficiencies under the 4PL and 5PL models when
the response curves are not too stiff but the D-optimal design and the extended
D-optimal design provide higher efficiencies all the time. For Study 2, the actual
design performs very well compared to the D-optimal design and the extended
D-optimal design. The designs, ξS1, ξS2, ξExD, and ξD become less efficient when
they are used for the 3PL model. In contrast, our proposed compromised design
ξRoD is quite robust to the model uncertainty since it provides much higher
efficiencies for the 3PL model while maintaining quite competitive efficiencies
for the 4PL and 5PL models.
Table 6 about here
7 Conclusions
We present optimal designs for studying several meaningful features of the 5PL
model, which has been shown it can fit bioassays data better than 3 or 4PL
models when the response curve is asymmetric. We compare performance of
the actual designs that are recommended for immunoassays and bioassays and
this paper provides quantitative evidence that the assays can be studied more
effectively using optimal designs discussed here. To facilitate users implement
optimal designs for the 5PL model, we provide an R package Opt5PL to assess
performance of the actual designs relative to the optimum, and also to study
robustness properties of the optimal design to various model assumptions. In
particular, we show that the locally D-optimal design for estimating the model
parameters in the 5PL model is relatively robust to mis-specified parameter
values for θ2,θ3 and θ5 and also to the form of the mean response. However, the
same robustness cannot be guaranteed when it is used for different objectives.
Additionally, we show more realistic designs, such as multiple-objective optimal
designs, should be used to capture the goals of the study more accurately. These
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designs tend to generally provide noticeably higher efficiencies for all objectives
than the single-objective optimal designs.
Our work is the first to address a variety of design issues for the 5PL model.
Additionally, we provide an R package to facilitate researchers in bioassays
and immunoassays to design more efficient experiments for the 3,4 and 5PL
models. Our focus here is on constructing locally optimal designs and future
directions for research include finding different types optimal designs using
the maximin, Bayesian and multistage approaches. Another interesting design
issue not discussed here is finding optimal designs for the 5PL model when the
data has heterogeneous variances. Sometimes bioassays data have heterogeneous
variances as the concentration changes. It is not known whether optimal designs
discussed here are robust to heteroscedastic errors in the model or whether use of
optimal designs based on other efficient estimators such as the maximum quasi
likelihood estimator(MqLE) or the extended quasi likelihood estimator(EQL) is
a better option.
Acknowledgement
Wong was partially supported by a grant from the National Institute of General
Medical Sciences of the National Institutes of Health under Award Number
R01GM107639. The content is solely the responsibility of the authors and does
not necessarily represent the official views of the National Institutes of Health.
Supplementary material
The following supporting information is available as part of the Supplementary
material:
Table A1 and Table A2. D-efficiencies, e5PLD , and c-efficiencies, e
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designs under the 5PL model with various values of θ2 and θ3.
Table A3. D- and c-efficiencies, e4PLD and e
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Table A8 and Table A9. The Robust D-optimal designs for the 5PL model
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Table 1. D-efficiencies, e5PLD , and c-efficiencies, e
5PL
c , of 4 designs under the 5PL model
with various values of θ5. The designs ξ
4PL
1 , ξ
4PL
2 , ξ
4PL
3 in the first 3 rows are the
cD-optimal designs found from the 3 ways assuming the 4PL model with nominal values
Θ2 = (1, 1, 1, 0) holds. The fourth design ξ
5PL
D is the D-optimal design for the 5PL
model constructed from nominal values Θ3 = (1, 1, 1, 0, 1). Zero efficiencies mean actual
efficiencies are smaller than 0.01.
Design ξ θ5 0.5 0.8 1.0† 1.2 1.5 1.8 2.0
ξ4PL1
(
−5.00 −0.60 −0.50 0.50 0.60 5.00
0.25 0.19 0.06 0.06 0.19 0.25
)
e5PLD 0.23 0.27 0.29 0.30 0.31 0.31 0.31
e5PLc 0.00 0.01 0.13 0.46 0.07 0.01 0.01
ξ4PL2
(
−5.00 −1.00 0.00 1.00 5.00
0.25 0.12 0.25 0.12 0.25
)
e5PLD 0.58 0.67 0.71 0.74 0.75 0.74 0.72
e5PLc 0.05 0.52 0.97 0.90 0.69 0.50 0.40
ξ4PL3
(
−5.00 −0.60 −0.50 0.50 0.60 5.00
0.25 0.21 0.04 0.04 0.21 0.25
)
e5PLD 0.22 0.25 0.27 0.28 0.29 0.29 0.29
e5PLc 0.00 0.01 0.11 0.45 0.06 0.01 0.01
ξ5PLD
(
−5.00 −1.96 −0.15 1.65 5.00
0.20 0.20 0.20 0.20 0.20
)
e5PLD 0.86 0.95 1.00 0.97 0.92 0.83 0.76
e5PLc 0.37 0.71 0.69 0.64 0.61 0.56 0.53
The true value of θ5
Table 2. D- and c-efficiencies, e4PLD and e
4PL
c of the 4 designs under the 4PL model
with various values of θ3(ED50). ξ
4PL
1 , ξ
4PL
2 , ξ
4PL
3 are the cD-optimal designs for the
4PL model with Θ2 = (1, 1, 1, 0) and ξ
5PL
D is the D-optimal design for the 5PL model
with Θ3 = (1, 1, 1, 0, 1).
Design θ3 0.5 0.8 1.0† 1.2 1.5 1.8 2.0
ξ4PL1 e
4PL
D 0.81 0.89 0.90 0.89 0.86 0.83 0.81
e4PLc 0.54 0.81 0.84 0.82 0.73 0.62 0.54
ξ4PL2 e
4PL
D 0.84 0.90 0.90 0.90 0.88 0.86 0.85
e4PLc 0.56 0.78 0.81 0.80 0.71 0.62 0.56
ξ4PL3 e
4PL
D 0.81 0.89 0.90 0.89 0.87 0.84 0.81
e4PLc 0.54 0.81 0.84 0.82 0.74 0.62 0.54
ξ5PLD e
4PL
D 0.89 0.89 0.90 0.91 0.91 0.91 0.91
e4PLc 0.54 0.55 0.55 0.55 0.54 0.55 0.55
The true value of θ3
Table 3. D-, c-, Ds-efficiencies (e
5PL
B
D , e
5PL
B
c , and e
5PL
B
Ds
) of the optimal designs for
5PLC when they are used for 5PLB with various values of θ5. Here 5PL
C and 5PLB
represents the 5PL models with a continuous response and a binary response respectively.
ξθ5
D
, ξθ5c , and ξ
θ5
Ds
are the sought D-, c-, and Ds- optimal designs under 5PL
C with the
given θ5 value in the column and ξ
∗
D is the sought D-optimal design under 5PL
C with
Θ3 = (1, 1, 1, 0, 1).
Efficiency θ5 0.5 0.8 1.0† 1.2 1.5 1.8 2.0
e5PL
B
D
ξθ5D 0.82 0.83 0.81 0.80 0.78 0.76 0.73
ξ∗D 0.80 0.81 0.81 0.82 0.82 0.81 0.79
e5PL
B
c
ξθ5c 0.48 0.67 0.65 0.59 0.29 0.59 0.57
ξ∗D 0.22 0.59 0.45 0.36 0.17 0.34 0.34
e5PL
B
Ds
ξθ5Ds 0.54 0.55 0.50 0.46 0.40 0.36 0.34
ξ∗D 0.29 0.31 0.32 0.34 0.36 0.34 0.31
The true value of θ5
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Table 4. The 6 sets of parameter values of the 5PL model for Study 1 and Study 2.
Case Study 1 Study2
c1 Θ = (30000, 0.5, 800, 0.5, 2.0) Θ = (100, 0.81, 40.14, 0, 1.63)
c2 Θ = (30000, 0.5, 800, 0.5, 5.0) Θ = (100, 0.93, 49.82, 0, 1.06)
c3 Θ = (30000, 1.0, 800, 0.5, 1.0) Θ = (100, 1.11, 69.26, 0, 0.59)
c4 Θ = (30000, 1.0, 800, 0.5, 1.5) Θ = (100, 0.80, 10.58, 0, 2.33)
c5 Θ = (30000, 2.0, 800, 0.5, 2.0) Θ = (100, 0.80, 12.12, 0, 2.33)
c6 Θ = (30000, 2.0, 800, 0.5, 5.0) Θ = (100, 0.83, 16.93, 0, 1.90)
Table 5. Efficiencies of the designs for various objectives of the 5PL model under the 6
sets of nominal values for each of Study 1 and 2. The locally D-optimal design, the
locally extended D-optimal design and the actual designs, are given, respectively by ξD,
ξExD, and ξS1 and ξS2.
Study Efficiency ξ c1 c2 c3 c4 c5 c6
1
eD
ξExD 0.91 0.91 0.91 0.91 0.91 0.91
ξS1 0.88 0.74 0.86 0.83 0.45 0.32
ec
ξD 0.82 0.85 0.71 0.66 0.55 0.57
ξExD 0.62 0.67 0.67 0.60 0.63 0.64
ξS1 0.55 0.30 0.55 0.47 0.03 0.35
eDs
ξD 0.84 0.83 0.86 0.85 0.86 0.85
ξExD 0.67 0.66 0.65 0.65 0.65 0.65
ξS1 0.59 0.35 0.56 0.48 0.05 0.04
Study Efficiency ξ c1 c2 c3 c4 c5 c6
2
eD
ξExD 0.91 0.91 0.91 0.91 0.91 0.91
ξS2 0.92 0.92 0.92 0.90 0.91 0.91
ec
ξD 0.88 0.90 0.88 0.89 0.90 0.90
ξExD 0.67 0.68 0.67 0.69 0.69 0.69
ξS2 0.68 0.68 0.66 0.63 0.64 0.66
eDs
ξD 0.84 0.85 0.85 0.85 0.84 0.85
ξExD 0.68 0.68 0.68 0.68 0.68 0.68
ξS2 0.66 0.66 0.66 0.61 0.62 0.63
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Table 6. D-efficiencies of the 4 designs, ξS1 and ξS2, ξExD, ξD, and ξRoD for the 3PL,
4PL and 5PL models under the 6 sets of nominal values for each of Study 1 and 2. ξRoD
is the robust D-optimal design with λ1 = λ2 = λ3 = 1/3 and e
3PL
D , e
4PL
D , e
5PL
D are,
respectively, the efficiencies of the given design for estimating the model parameters in
the 3PL, 4PL, and 5PL models.
Study 1
Θ ξ e3PLD e
4PL
D e
5PL
D Θ ξ e
3PL
D e
4PL
D e
5PL
D
c1 ξS1 0.60 0.83 0.88 c4 ξS1 0.51 0.81 0.83
ξExD 0.69 0.85 0.91 ξExD 0.70 0.86 0.91
ξD 0.69 0.91 1.00 ξD 0.68 0.91 1.00
ξRoD 0.80 0.94 0.94 ξRoD 0.79 0.93 0.95
c2 ξS1 0.40 0.73 0.74 c5 ξS1 0.33 0.66 0.45
ξExD 0.67 0.84 0.91 ξExD 0.70 0.87 0.92
ξD 0.67 0.91 1.00 ξD 0.66 0.90 1.00
ξRoD 0.80 0.94 0.94 ξRoD 0.80 0.94 0.93
c3 ξS1 0.58 0.83 0.86 c6 ξS1 0.20 0.46 0.32
ξExD 0.71 0.86 0.91 ξExD 0.71 0.87 0.92
ξD 0.69 0.90 1.00 ξD 0.66 0.90 1.00
ξRoD 0.80 0.93 0.95 ξRoD 0.80 0.94 0.94
Study 2
Θ ξ e3PLD e
4PL
D e
5PL
D Θ ξ e
3PL
D e
4PL
D e
5PL
D
c1 ξS2 0.84 0.86 0.92 c4 ξS2 0.86 0.86 0.90
ξExD 0.82 0.84 0.91 ξExD 0.84 0.84 0.91
ξD 0.85 0.90 1.00 ξD 0.88 0.90 1.00
ξRoD 0.90 0.94 0.97 ξRoD 0.92 0.94 0.97
c2 ξS2 0.85 0.86 0.92 c5 ξS2 0.86 0.86 0.91
ξExD 0.83 0.84 0.91 ξExD 0.84 0.84 0.91
ξD 0.88 0.90 1.00 ξD 0.87 0.90 1.00
ξRoD 0.92 0.93 0.97 ξRoD 0.92 0.94 0.97
c3 ξS2 0.83 0.86 0.92 c6 ξS2 0.85 0.86 0.91
ξExD 0.82 0.84 0.91 ξExD 0.84 0.84 0.91
ξD 0.87 0.90 1.00 ξD 0.87 0.90 1.00
ξRoD 0.91 0.94 0.97 ξRoD 0.92 0.94 0.97
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Figure 1. Response curves for Study 1. The mean responses at design points in ξS1 are
plotted.
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Figure 2. Response curves for Study 2. The mean responses at design points in ξS2 are
plotted.
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